Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Accumulated Expenses (2020 - 2024)

Pulmonx (LUNG) has disclosed Accumulated Expenses for 4 consecutive years, with $16.5 million as the latest value for Q4 2024.

  • Quarterly Accumulated Expenses rose 1.47% to $16.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $16.5 million through Dec 2024, up 1.47% year-over-year, with the annual reading at $16.5 million for FY2024, 1.47% up from the prior year.
  • Accumulated Expenses for Q4 2024 was $16.5 million at Pulmonx, up from $16.2 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $16.5 million in Q4 2024, with the low at $8.7 million in Q4 2020.
  • Average Accumulated Expenses over 4 years is $13.7 million, with a median of $14.8 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses rose 22.28% in 2023, then increased 1.47% in 2024.
  • Over 4 years, Accumulated Expenses stood at $8.7 million in 2020, then soared by 53.46% to $13.3 million in 2022, then grew by 22.28% to $16.2 million in 2023, then increased by 1.47% to $16.5 million in 2024.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $16.5 million, $16.2 million, and $13.3 million for Q4 2024, Q4 2023, and Q4 2022 respectively.